Our History & Technology
J. H. Hare & Associates Ltd. is a family-owned Canadian company with deep roots in animal agriculture since 1970. In 1997, we pioneered Hyper-Egg® Antibody Technology—harnessing eggs from hyper-immunized laying hens to combat enteric infections in animals and humans.
"The Premier Alternative to Antibiotics & Zinc"
With regulated removal of growth-promoting antibiotics and impending zinc restrictions in animal feeds, Hyper-Egg® delivers sustainable solutions for modern animal agriculture.
Key Achievements
World's First Registered Veterinary Biologic
Licensed by the Canadian Centre for Veterinary Biologics/CFIA
Establishment License: #58
Veterinary Biologics File: #880AY-E1.0-N17
Prevents E. coli-induced diarrhea in piglets - a breakthrough in animal health.
Global Reach
The Hyper-Egg® Advantage
Fixed antibody titres in every batch
Every batch monitored by CFIA
Natural alternative to antibiotics
Consistent animal health results
As the world's only registered polyclonal egg antibody veterinary biologic, Hyper-Egg® sets the standard for effective, natural animal health solutions.
Why Producers Trust Us
Hyper-Egg® products are the world's only registered polyclonal egg antibody veterinary biologics. This means:
- Every production batch undergoes rigorous CFIA oversight
- Consistent antibody titres are guaranteed
- Products meet the highest regulatory standards
- Producers achieve sustainable animal health outcomes
- Performance results are reliable and repeatable
With Hyper-Egg®, producers have a scientifically validated, naturally derived solution for enteric health challenges.